Kelsey Satterly

1. STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD ® ) Device, in Healthy Adult Subjects
   2019/01/19 by Stephen B. Shrewsbury, Maria Jeleva, Kelsey Satterly +2 · 1 voice · 1 citation
   Medicine · Neuroscience · #Migraine and Headache Studies #Olfactory and Sensory Function Studies #Respiratory and Cough-Related Research